Latin America: Towards Medicine Sovereignty
When it comes to pharmaceutical exports, Latin America has historically been confined to the margins of the global life science industry. In 2023, the region accounted for a mere one…
Address: R. Cônego Felipe, 365 – Taquara – Rio de Janeiro – RJ CEP: 22713-010,Brazil
Tel: (21) 2159-2600
Laboratórios Bagó do Brasil is a pharmaceutical company outlined by its competencies of innovation and vision of the future. The company is an important part of Bagó Group founded in 1934, in Argentina. Established in the country in 2002, its founders have created an organization with a solid reputation based on ethics and commitment to quality.
The slogan “Ethics at the service of Heath” holds an special place on guiding the company’s actions, and so does the premium, the priority ingredient of the organization’s roles.
With a head office and a plant in the city of Rio de Janeiro, a distribution center in Brasilia and representatives in the major centers of consumption in the country, the company develops, distributes and commercializes innovative pharmaceutical products.
With an excellence and reliability standing, the company progressively attracts more attention and the trustiness of the country’s medical class, acquiring the respect of Brazilian’s consumers.
Keflex
When it comes to pharmaceutical exports, Latin America has historically been confined to the margins of the global life science industry. In 2023, the region accounted for a mere one…
Dirk van Niekerk, President and CEO of Boehringer Ingelheim South America, identifies Latin America as a pivotal growth engine. Focusing on cardio, renal, metabolic and oncology pillars, the firm is…
Fernando Almeida, EVP China & International Markets, discusses his global pharma career and Chiesi’s evolution into a high-performing, innovation-led group. He highlights strong double-digit growth, disciplined investment, and expansion across…
From cancer treatments to cardiovascular drugs, access to innovative medicines in South America lags behind developed market norms with patients forced to endure considerable delays for therapies that are already…
Latin America faces one of the most complex healthcare landscapes in the world, where fast-growing demand collides with deep structural inequities and limited resources. In this interview, Fabrizio Signorin, President…
Marco Billi, International CEO of Eurofarma, shares his perspective on the company’s evolution from a Brazilian CMO (Contract Manufacturing Organisation) into one of Latin America’s most internationally active pharmaceutical groups.…
Latin America’s largest and most dynamic pharma market is booming. Despite sluggish macroeconomic growth, agile local firms are consolidating their positions to serve Brazilian patients, while a spate of technology…
Danielle Bibas leads Pierre Fabre’s operations in Brazil, overseeing three key dermo-cosmetic brands – Avène, Darrow, and Ducray – in the world’s third-largest beauty market. Since assuming the role in…
Rare diseases have long fallen through the cracks of Latin America’s health systems, but few figures have done more to change that reality than Toni Daher. What started as a…
Brazil’s push to modernise its health system has put Interfarma at the centre of the region’s biggest access debate. Since taking over the presidency in 2023, Renato Porto has steered…
Alexandre Gibim, senior Vice President of Latin America at AstraZeneca, brings extensive global pharmaceutical leadership experience spanning China, the US, and Canada. In this exclusive interview, he articulates AstraZeneca’s strategic…
Haig Yeghiaian, General Manager at LEO Pharma Brazil, brings extensive therapeutic area expertise spanning HIV, nephrology, and dermatology to his leadership of the company’s multifaceted Brazilian operations. Under his stewardship,…
See our Cookie Privacy Policy Here
